<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-131656</identifier>
<setSpec>1695-4033</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Respiratory syncitial virus in immunocompromised patients in a pediatric hospital: 5 years experience</dc:title>
<dc:description xml:lang="en">Introduction: Respiratory syncytial virus (RSV) infection is associated with an increase in morbidity and mortality in immunocompromised hosts. Methods: A description is presented of all cases of RSV infection in immunocompromised pediatric patients in Hematology and Oncology and Immunodeficiency Units between 2008 and 2012. Results: Nineteen patients were diagnosed with RSV infection. Nine patients required in-patient care and 2 required Pediatric Intensive Care Unit. Five patients were treated with specific therapy (ribavirin ± palivizumab). No deaths occurred in the study period. Conclusion: RSV infection may be severe in immunocompromised pediatric patients (AU)</dc:description>
<dc:creator>Baro Fernández, M</dc:creator>
<dc:creator>Domínguez Pinilla, N</dc:creator>
<dc:creator>belda Hofheinz, S</dc:creator>
<dc:creator>Vivanco Martinez, J. L</dc:creator>
<dc:creator>Ruiz Contreras, J</dc:creator>
<dc:creator>González Granado, L. I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: La infección por virus respiratorio sincitial (VRS) causa importante morbimortalidad en pacientes inmunodeprimidos. Métodos: Estudio descriptivo en un hospital pediátrico de los casos de infección por VRS en pacientes inmunodeprimidos de las unidades de Hemato-Oncología e Inmunodeficiencias en el periodo 2008-2012. Resultados: Se diagnosticaron 19 casos de infección por VRS. Nueve pacientes requirieron ingreso, 2 en Unidad de Cuidados Intensivos Pediátrica. Cinco pacientes precisaron tratamiento  con ribavirina y/o palivizumab. No se produjeron fallecimientos. Conclusión: La infección por VRS es potencialmente grave en los pacientes pediátricos inmunodeprimidos(AU)</dc:description>
<dc:source>An Pediatr (Barc);82(1): 35-40, ene. 2015. tab</dc:source>
<dc:identifier>ibc-131656</dc:identifier>
<dc:title xml:lang="es">Infección por virus respiratorio sincitial en los pacientes inmunodeprimidos en un hospital pediátrico: experiencia de 5 años</dc:title>
<dc:subject>^d21079^s22016</dc:subject>
<dc:subject>^d10565^s37748</dc:subject>
<dc:subject>^d6622^s22012</dc:subject>
<dc:subject>^d21079^s22047</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d10565^s22060</dc:subject>
<dc:subject>^d36007^s22016</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29640</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6622^s22016</dc:subject>
<dc:subject>^d36007^s22012</dc:subject>
<dc:subject>^d10565^s22019</dc:subject>
<dc:subject>^d36007^s22044</dc:subject>
<dc:subject>^d21079^s22044</dc:subject>
<dc:subject>^d21079^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201501</dc:date>
</metadata>
</record>
</ibecs-document>
